Swiss pharma giant Roche says it has received Emergency Use Authorization from the United States for a test to quickly detect whether a patient has Covid-19 or one of two forms of influenza.
This content was published on
1 minute
Reuters/swissinfo.ch/ilj
Español
es
Roche obtiene aprobación para pruebas de coronavirus y gripe
The company said in a statement on FridayExternal link that it had received the go-ahead from the US Food and Drug Administration for the test be used in certain approved laboratories for the duration of the declaration. It will also be available in markets accepting the CE mark, Roche said.
The test is intended for the simultaneous detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected of having respiratory viral infection consistent with Covid-19, Roche said.
“With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone,” said Roche diagnostics head Thomas Schinecker. “Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients.”
The test will be for use on Roche’s Cobas 6800/8800 systems, which are capable of handling large volumes and are often found in hospitals. They can perform 96 tests within three hours, the company said.
Swiss money laundering office registers record number of reports
This content was published on
The Money Laundering Reporting Office Switzerland (MROS) registered a record number of reports of suspicious activity last year.
Two teens accused of planning terror attack released from custody
This content was published on
The Schaffhausen judiciary has released the two teenagers from custody who allegedly planned bomb attacks in Switzerland.
OECD: Sluggish economic activity slowing growth in Switzerland
This content was published on
Sluggish economic activity at the start of the year is weighing on growth in Switzerland, with GDP expected to fall to 1.1% in 2024.
Report finds mistakes which led to Swiss government data breach
This content was published on
Mistakes were made by both the government and internet company Xplain in the case of a criminal cyber-attack on the Bern-based IT business.
Swiss government wants better gender balance in federal administration
This content was published on
New Swiss government personnel management targets say there must be even more female managers in the federal administration.
Swiss national science foundation funded over 5,000 projects in 2023
This content was published on
In 2023, the Swiss National Science Foundation (SNSF) provided a total of CHF961 million worth of funding towards research projects.
Switzerland invites 160 delegations to June Ukraine peace talks
This content was published on
Russia is currently not among the delegations invited to talks aimed at helping bring about peace in the conflict between Moscow and Ukraine.
Survey: air travel most popular way to go on holidays for Swiss
This content was published on
Despite the climate crisis, flying is the most popular mode of transport for private travel – particularly among young, urban and high-income travellers.
Swiss government to use phone data to identify asylum seekers
This content was published on
From April 2025, authorities plan to be able to analyse data from mobile phones, computers and other data carriers to identify asylum seekers.
Roche working ‘around the clock’ to provide coronavirus test
This content was published on
After getting the green light to deploy its coronavirus diagnostic test, Roche says it is working around the clock to make it available.
Roche boss who says bitter pill of truth is only way to build trust
This content was published on
Severin Schwan talks a lot about trust. Trust in people you live with, socialise with, work with. And trust is not won by being nice.
This content was published on
With its big bet on data and digitilisation, Roche has its eye on a new crop of specialists. Now it just needs to woo them.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.